(Bloomberg) — Citigroup Inc., Qantas Airways Ltd. and Singapore’s United Overseas Bank Ltd. joined companies worldwide making deeper cost cuts, from property and equipment to staff and pay, as the pandemic persists.
A U.K. court ruling in a landmark insurance case could lead to tens of millions of payouts related to Covid-19. Britain’s labor market took a turn for the worse in July, taking total job losses during the crisis to almost 700,000, fresh data showed.
In India, where infections trail only the U.S., total cases approached 5 million. Hong Kong reported no locally transmitted infections for the first time since early July. The city injected its struggling economy with fresh stimulus and lifted some social distancing measures, including temporarily reopening bars.
A vaccine may be available for “ordinary Chinese” as soon as November, the state-owned Global Times newspaper said.
Global Tracker: Cases pass 29.2 million; deaths exceed 928,900Lagarde leverages virus to push for greener monetary policyThis year’s wine harvest may be the most troubled everThe Carnival cruise ship that spread the virus to the worldWorkplace virus cleaning poses disability litigation risksVaccine trials face their moment of truthBill Gates on pandemic, vaccines (video)
Subscribe to a daily update on the virus from Bloomberg’s Prognosis team here. Click CVID on the terminal for global data on coronavirus cases and deaths.
FCA, Policyholders Call Insurance Ruling a ‘Victory’ (6:31 a.m. NY)
Lawyers for policyholders in a landmark U.K. insurance case over payouts related to Covid-19 called the ruling a “resounding victory” for their clients. The Financial Conduct Authority said insurers should be begin progressing claims in light of the ruling from a pair of London judges on Tuesday.
Shares in Hiscox Ltd. and RSA Insurance Group Plc gained after the companies responded to the ruling, providing estimates of the impact. The insurers, together with Zurich Insurance Group AG and five other companies, had objected to the FCA case, which was brought in an effort to bring legal clarity to dozens of policies under dispute.
BioNTech Gets $445 Million in German Funding for Shot (6:30 a.m. NY)
BioNTech SE will get as much as 375 million euros ($445 million) from Germany to back its Covid-19 program, about half of the money the government set aside to accelerate development of a vaccine.
The German biotech company is working with Pfizer Inc. and Shanghai Fosun Pharmaceutical Group Co. on what is expected to be one of the first vaccines to deliver results from late-stage trials. Pfizer has repeatedly said data from a U.S. study could be ready next month.
Iran’s New Cases at Highest in Six Weeks (6:20 a.m. NY)
The number of new cases in Iran climbed for a second day to 2,705, the highest in six weeks, taking the total to 407,353. The death toll reached 23,453 with 140 more fatalities, down from a four-week high of 156 the previous day, Health Ministry data showed.
At least two Iranian members of parliament have gone into quarantine after testing positive, the semi-official Tasnim news agency reported.
Russia’s Daily Deaths, Cases Highest Since July (4:31 p.m. HK)
Russia’s new cases and deaths rose the most since late July as the virus spread with the return of millions to school and work. The government reported 5,529 new cases and 150 deaths.
“Many people are coming back from vacations, schoolchildren and students started their studies — several risk factors coincided at once,” Prime Minister Mikhail Mishustin said Monday at a televised meeting of officials on the virus.
Moscow isn’t planning new restrictions to limit the spread in the city, according to Mayor Sergei Sobyanin. Russia has reported a total of 1.07 million cases, ranking it fourth in the world behind the U.S., India and Brazil.
U.K. Says ‘No Magic Solution’ for Struggling Test System (4:23 p.m. HK)
Boris Johnson’s government acknowledged its Covid-19 testing program is coming under strain.
“This is challenging,” Home Secretary Priti Patel told Times Radio on Tuesday. “There is no magic solution to say this is all going to be perfect.” On Monday, LBC Radio reported there were no walk-in, drive-through or home tests accessible online in the worst-affected virus areas, including Bolton, Salford, Blackburn and Manchester.
Separately, the Office for National Statistics said fatalities in England and Wales fell 14% in the week ended Sept. 4, dropping below average for the first time in four weeks.
Mizuho Dials Back Return to London Office (3:03 p.m. HK)
Mizuho International Plc tempered a move to allow all of its staff back to the Japanese bank’s London office amid a new wave of U.K. cases.
The firm told workers Friday in a memo that only employees performing “business critical” roles can return to its office near St. Paul’s Cathedral, which normally houses about 1,400 staff. Monday was the first day the policy applied at Mizuho, which had previously given all staff the choice to return as long as the building’s capacity didn’t exceed 50%.
Britain’s Job Losses (2:15 p.m. HK)
Britain has lost almost 700,000 jobs to the coronavirus crisis, a blow to the economy that will heap further pressure on the government to extend its wage-support programs.
The number of employees on payrolls in August is down 695,000 from March, the Office for National Statistics said Tuesday. The number of people claiming for jobless benefits has risen to 2.7 million, an increase of 121% since March.
Indian Economy Set to Shrink 9% (1:46 p.m. HK)
India is likely to see its economy contract 9% this year, the worst performance among major developing economies in Asia, according to the Asian Development Bank. The country added nearly 84,000 infections on Tuesday to take the total tally past 4.9 million. Deaths rose by 1,054 to cross 80,000.
The ADB estimates that developing Asia will shrink for the first time since the early 1960s. “The economic threat posed by the Covid-19 pandemic remains potent, as extended first waves or recurring outbreaks could prompt further containment measures,” Yasuyuki Sawada, ADB’s chief economist, said in a live-streamed briefing.
Myanmar’s Growing Hotspot (1:22 p.m. HK)
Myanmar authorities are rushing to manage a growing number of infections in the country’s largest city, Yangon. Three government rapid-response teams arrived early Tuesday to support the treatment of patients in the city, where only one of 44 townships remains virus free.
The Thuwanna National Football Academy in Yangon has been turned into a 400-bed hospital tent, and some high schools have been temporarily transformed into quarantine centers. Myanmar reported 104 new cases Tuesday, taking the total to 3,299. The death toll was unchanged at 32.
Hong Kong Airlines Slashes Pilot Pay (11:25 a.m. HK)
Hong Kong Airlines will cut income and allowances for pilots by 60% from October to March, and extend an unpaid leave program. Pilots will be rostered for one month of duty, followed by two months of unpaid leave, a spokesman for the airline said.
U.K. Eviction-Ban Extension: FT (11:10 a.m. HK)
The U.K. is preparing to extend a ban preventing commercial tenants from being evicted by landlords until the end of the year, the Financial Times reported, citing two unidentified people briefed on the situation.
Government officials are examining how to prolong the ban from its current deadline of Sept. 30, and an announcement could come as early as this week, the newspaper said.
Broad China Vaccine Flagged for November (8:50 a.m. HK)
A Covid-19 vaccine may be available for “ordinary Chinese” as soon as November or early December following a Phase III trial that “went very smoothly,” the Global Times said in a tweet, citing the Chinese CDC’s chief biosafety expert.
George Washington Enrollment Sinks (8:48 a.m. HK)
George Washington University’s enrollment is down about 17% from last year, an early indication of the impact of Covid-19 on U.S. higher education. President Thomas LeBlanc told a faculty senate meeting that preliminary undergraduate enrollment is about 1,000 students below its target of 10,126, a spokeswoman said Monday.
Hong Kong Concludes Mass Test (8:40 a.m. HK)
Hong Kong concluded a Beijing-backed campaign to offer everyone in the city a free virus test. Health experts see the drive as an additional weapon against the disease and preparation for any flareups.
Close to 1.8 million residents — about a quarter of the city’s population — completed tests over the past two weeks, through which at least 32 new infections were identified, according to government data.
Participation trailed the 3 million turnout hoped for by the lab running the project.
Qantas Considers HQ Move (8:06 a.m. HK)
The Australian airline said it’s considering moving its headquarters from Sydney as part of an office and property review to cut costs.
“Like most airlines, the ongoing impact of Covid means we’ll be a much smaller company for a while,” Chief Financial Officer Vanessa Hudson said.
Singapore Bank UOB Freeze’s Pay and Hiring (7:52 a.m. HK)
United Overseas Bank Ltd. imposed a freeze on hiring, pay and promotions as the Singapore lender prepares for a further decline in earnings after the pandemic.
The city state’s third-largest bank told staff that it expects the situation to worsen before improving when the government cuts some of its support, according to an internal memo sent to senior staff. The hiring freeze will last until December 2021, and any exceptions will need senior approval.
Citigroup Resumes Job Cuts (7:20 a.m. HK)
Citigroup Inc. will resume job cuts this week, joining rivals such as Wells Fargo & Co. in ending an earlier pledge to pause staff reductions during the coronavirus pandemic.
The cuts will affect less than 1% of the bank’s global workforce, the bank said in a statement. With recent hiring, overall headcount probably won’t show any drops, the bank said.
Astra Trial on Hold Pending U.S. Scrutiny: Reuters (4:30 p.m. NY)
AstraZeneca Plc’s Covid-19 vaccine trial remains on hold in the U.S. as regulators examine a serious side effect suffered by a U.K. patient, Reuters reported.
The drugmaker and its partner, the University of Oxford, restarted the U.K. trial of the vaccine on Saturday after it was halted on Sept. 6. The U.K. Medicines Health Regulatory Authority recommended the study resume after an independent review of the safety data had triggered the pause.
However, enrollment of new study participants and other trial procedures remain stopped in the U.S. pending an investigation by the Food and Drug Administration and an independent safety panel, Reuters reported, citing unnamed sources.
For more articles like this, please visit us at bloomberg.com
Subscribe now to stay ahead with the most trusted business news source.
©2020 Bloomberg L.P.